三菱综合研究所(MRI)与安斯泰来制药公司宣布达成谅解备忘录,共同助力日本新药研发初创企业拓展全球市场。MRI将基于其在MEDISO项目中的经验,为参与企业量身定制支持方案。安斯泰来则提供实验室及办公空间,进一步推动MEDISO加速计划中的药物发现初创企业发展。此次合作旨在整合双方资源,为初创企业创造国际化机遇。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.